Oncaspar 750 U/ml powder for solution for injection/infusion

DRUG3 trials

Sponsors

Charite Universitaetsmedizin Berlin KöR, Semmelweis University

Conditions

Childhood non-mature-B Acute Lymphoblastic LeukemiaRelapsed Acute Lymphoblastic Leukemia (ALL)

Phase 2

International Study for Treatment of High Risk Childhood Relapsed ALL 2010 - A randomized Phase II Study Conducted by the Resistant Disease Committee of the International BFM Study Group – IntReALL HR 2010

Active, not recruitingCTIS2024-513070-21-00

Charite Universitaetsmedizin Berlin KöRRelapsed Acute Lymphoblastic Leukemia (ALL)

Start: 2018-02-15Target: 222Updated: 2025-09-17

Phase 3

International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 - A Randomized Phase III Study Conducted by the Resistant Disease Committee of the International BFM Study Group - IntReALL BCP 2020

Not yet recruitingCTIS2023-509392-17-00

Charite Universitaetsmedizin Berlin KöRRelapsed Acute Lymphoblastic Leukemia (ALL)

Target: 765Updated: 2025-12-15

Phase 4

A Randomized Trial of the I-BFM-SG for the Management of Childhood non-mature-B Acute Lymphoblastic Leukemia

Not yet recruitingCTIS2024-513824-41-00

Semmelweis UniversityChildhood non-mature-B Acute Lymphoblastic Leukemia

Target: 775Updated: 2025-01-13